A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease

被引:29
作者
Warren, L. [1 ,1 ]
Gibson, R. [2 ]
Ishihara, L. [3 ]
Elango, R. [2 ]
Xue, Z. [1 ]
Akkari, A. [1 ]
Ragone, L.
Pahwa, Rajesh [4 ]
Jankovic, Joseph [5 ]
Nance, Martha
Freemang, Alan [6 ]
Watts, Ray L. [7 ]
Hentati, F. [8 ]
机构
[1] GlaxoSmithKline Inc, Res & Dev, Res Triangle Pk, NC USA
[2] GlaxoSmithKline Inc, Res & Dev, Greenford UB06 0NN, Middx, England
[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England
[4] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS USA
[5] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA
[6] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
[7] Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA
[8] Inst Natl Neurol, Serv Neurol, Tunis 1007, Tunisia
关键词
Parkinson's disease; LRRK2; G2019S; founder haplotype;
D O I
10.1016/j.parkreldis.2007.02.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The Leucine-rich repeat kinase 2 (LRRK2) gene has been identified as a disease susceptibility gene for Parkinson's disease (PID), with G2019 (6055G > A) being the most frequent mutation. This mutation was present in 42% (38/91) of Tunisian families and 2% (1/39) of US families we have studied. A founding haplotype was identified in our data and it is shared by families from Tunisia, US, European and Middle Eastern countries. The most recent common founder of the mutation was dated to 2600 (95% CI: 1950-3850) years ago although additional studies are warranted to ensure an accurate age estimate for this mutation. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:77 / 80
页数:4
相关论文
共 7 条
[1]   Merlin-rapid analysis of dense genetic maps using sparse gene flow trees [J].
Abecasis, GR ;
Cherny, SS ;
Cookson, WO ;
Cardon, LR .
NATURE GENETICS, 2002, 30 (01) :97-101
[2]   Estimating the age of rare disease mutations: the example of Triple-A syndrome [J].
Genin, E ;
Tullio-Pelet, A ;
Begeot, F ;
Lyonnet, S ;
Abel, L .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (06) :445-449
[3]   WHAT FEATURES IMPROVE THE ACCURACY OF CLINICAL-DIAGNOSIS IN PARKINSONS-DISEASE - A CLINICOPATHOLOGICAL STUDY [J].
HUGHES, AJ ;
BENSHLOMO, Y ;
DANIEL, SE ;
LEES, AJ .
NEUROLOGY, 1992, 42 (06) :1142-1146
[4]   Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations [J].
Ishihara, Lianna ;
Warren, Liling ;
Gibson, Rachel ;
Amouri, Rim ;
Lesage, Suzanne ;
Durr, Alexandra ;
Tazir, Meriem ;
Wszolek, Zbigniew K. ;
Uitti, Ryan J. ;
Nichols, William C. ;
Griffith, Alida ;
Hattori, Nobutaka ;
Leppert, David ;
Watts, Ray ;
Zabetian, Cyrus P. ;
Foroud, Tatiana M. ;
Farrer, Matthew J. ;
Brice, Alexis ;
Middleton, Lefkos ;
Hentati, Faycal .
ARCHIVES OF NEUROLOGY, 2006, 63 (09) :1250-1254
[5]   Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease [J].
Paisán-Ruíz, C ;
Jain, S ;
Evans, EW ;
Gilks, WP ;
Simón, J ;
van der Brug, M ;
de Munain, AL ;
Aparicio, S ;
Gil, AM ;
Khan, N ;
Johnson, J ;
Martinez, JR ;
Nicholl, D ;
Carrera, IM ;
Pena, AS ;
de Silva, R ;
Lees, A ;
Martí-Massó, JF ;
Pérez-Tur, J ;
Wood, NW ;
Singleton, AB .
NEURON, 2004, 44 (04) :595-600
[6]   LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East:: Evidence of two distinct founding events beginning two millennia ago [J].
Zabetian, Cyrus P. ;
Hutter, Carolyn M. ;
Yearout, Dora ;
Lopez, Alexis N. ;
Factor, Stewart A. ;
Griffith, Alida ;
Leis, Berta C. ;
Bird, Thomas D. ;
Nutt, John G. ;
Higgins, Donald S. ;
Roberts, John W. ;
Kay, Denise M. ;
Edwards, Karen L. ;
Samii, Ali ;
Payami, Haydeh .
AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 79 (04) :752-758
[7]   Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology [J].
Zimprich, A ;
Biskup, S ;
Leitner, P ;
Lichtner, P ;
Farrer, M ;
Lincoln, S ;
Kachergus, J ;
Hulihan, M ;
Uitti, RJ ;
Calne, DB ;
Stoessl, AJ ;
Pfeiffer, RF ;
Patenge, N ;
Carbajal, IC ;
Vieregge, P ;
Asmus, F ;
Müller-Myhsok, B ;
Dickson, DW ;
Meitinger, T ;
Strom, TM ;
Wszolek, ZK ;
Gasser, T .
NEURON, 2004, 44 (04) :601-607